Interactions with Healthcare Professionals and patients

Lundbeck works with healthcare professionals when developing and delivering new treatment options to people living with psychiatric and neurological diseases. We believe this collaborative working benefits patients and society.

Research & Development (R&D)

Lundbeck undertakes research activities and conducts clinical studies globally. Clinical studies are conducted in accordance with international guidelines and performed by HCPs and HCOs. Our payments and other transfers of value related to pre-clinical, clinical and non-interventional studies are disclosed in aggregate.

 

  R&D payments to HCPs & HCOs    
Country 2015 2016 2017 2018 2019
Bulgaria €579,823 €319,234 €661,840 €1,349,624 €961,636
Croatia 95,822 HRK 303,693 HRK €24,431 €295 €720
Estonia - - €492,586 €235,171 €449,747
Hungary €8,507 €30,128 €107,946 €52,271 €35,647
Latvia See country overview €83,105 €199,889 €164,272 €229,770
Lithuania €403,371 €229,952 €77,033 - €1,372
Serbia €251,289 Affiliate closed - - -
Ukraine €896,803 €359,207 €99,857 €452,015 €267,937

The amounts cover payments and other transfers of value to HCPs and HCOs related to pre-clinical, clinical and non-interventional studies in the countries where the Lundbeck affiliate uses Lundbeck’s corporate website for disclosure in accordance with the EFPIA Disclosure Code.

Data from other countries can be found on the Country overview tab.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.